Healthy male and females (ages 21 to 35) who have used PARTY DRUGS (e.g. meth, molly, ecstasy, cocaine) and who are recreational smokers of MARIJUANA are needed for a study of the effects of drugs on mood, …
Originally appearing here. Eighteen states (plus the District of Columbia) allow cannabis use for certain medical conditions. Despite that, scientists have a harder time doing research on the potential …
Originally appearing here. The US First Circuit Court of Appeals in Boston Monday sided with the Drug Enforcement Administration (DEA) in rejecting University of Massachusetts-Amherst scientist Dr. Lyle …
Originally appearing here. As more states embrace legalized marijuana, the drug’s growing medicinal use has highlighted a disturbing fact for doctors: scant research exists to support marijuana’s …
Medical Marijuana Workshop Space is limited—Register for the workshop here. Monday, 22 April 2013, 9:00 am - 5:00 pm This workshop is located in the Spinnaker Room II at the Waterfront Hotel, 10 …
Originally appearing here. The Massachusetts Medical Society, which steadfastly opposed the medical marijuana ballot question approved by voters in November, called on Friday for large-scale research of …
Beyond THC: Cannabidiol and the Future of Medical Marijuana Martin A. Lee, Author, Smoke Signals Cannabidiol (CBD), a nonpsychoactive component of marijuana, has extraordinary therapeutic qualities, claims …
Originally appearing here. In the face of obstacles to marijuana research from both the Drug Enforcement Administration and the National Institute on Drug Abuse, a theoretical physicist at the California …
Originally appearing here. A bill that would allow Arizona colleges and universities to conduct medical marijuana research on campus has advanced in the state Legislature. Senate Bill 1443 would exempt …
Originally appearing here. BOSTON — Although Massachusetts is now the 18th state to allow the medical use of marijuana, scientists continue to grapple with understanding the properties of the drug …
On Thursday, February 7, the Center for Law and the Biosciences and the Stanford Interdisciplinary Group in Neuroscience and the Law (SIGNAL) will host MAPS’ founder and executive director, Rick …
Originally appearing here. Dear Mr. Robert Bonner, Hello from Rick Doblin, Ph.D.,(Public Policy, Kennedy School of Government, Harvard University, with my dissertation on the regulation of the medical …
